Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 1,648 | 25,941 | 1,460 | 540 | 371 |
| Gross Profit | 1,648 | 25,508 | 1,460 | 540 | 371 |
| Operating Expenses | 16,133 | 11,307 | 17,218 | 18,784 | 20,310 |
| Operating Income | -14,485 | 14,634 | -15,758 | -18,244 | -19,939 |
| Other Income | 245 | 256 | 54 | 1,172 | -16,748 |
| Pre-tax Income | -14,240 | 14,890 | -15,704 | -17,072 | -36,687 |
| Net Income Continuous | -14,240 | 14,890 | -15,704 | -17,072 | -36,687 |
| Net Income | $-14,240 | $14,890 | $-15,704 | $-17,072 | $-36,687 |
| EPS Basic Total Ops | -4.80 | 7.36 | -5.26 | -5.80 | -15.60 |
| EPS Basic Continuous Ops | -4.75 | 7.35 | -5.26 | -5.75 | -15.65 |
| EPS Diluted Total Ops | -4.80 | 7.36 | -5.26 | -5.80 | -15.60 |
| EPS Diluted Continuous Ops | -4.75 | 7.35 | -5.26 | -5.75 | -15.65 |
| EBITDA(a) | $-14,257 | $14,857 | $-15,541 | $-18,038 | $-17,900 |